There was a 1.9- and 2.1-fold increase in the level of cleaved PARP when treated with ALS at 1 and 5 μM for 48 h, respectively, compared to the control cells (p < 0.01; Figure 5B and Figure S5B). The gene discussed is PARP1; the disease is amyotrophic lateral sclerosis.